DrugPatentWatch Database Preview
Profile for Austria Patent: 538794
» See Plans and Pricing
US Patent Family Members and Approved Drugs for Austria Patent: 538794
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Jan 12, 2020 | Bayer Hlthcare | NEXAVAR | sorafenib tosylate |
Start Trial | Jun 28, 2022 | Bayer Hlthcare | STIVARGA | regorafenib |
Start Trial | Jan 12, 2020 | Bayer Hlthcare | NEXAVAR | sorafenib tosylate |
Start Trial | Jan 12, 2020 | Bayer Hlthcare | NEXAVAR | sorafenib tosylate |
Start Trial | Jan 12, 2020 | Bayer Hlthcare | NEXAVAR | sorafenib tosylate |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |